Galectin Therapeutics (GALT) Debt Ratio (2024 - 2026)
Galectin Therapeutics' (GALT) Debt Ratio stood at 2.23 in Q2 2026.
Powered by 
Analysis
Galectin Therapeutics (GALT) Debt Ratio (2024 - 2026) Analysis & Trends
For FY2024, Galectin Therapeutics' Debt Ratio came in at 1.21.
- The Q2 2026 figure is the lowest quarterly Debt Ratio since Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Galectin Therapeutics | 259.28 Mn | 259.28 Mn | - | 2.23 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 |
| Sep 30, 2025 | 2.53 |
| Mar 31, 2025 | 2.23 |
| Dec 31, 2024 | 1.21 |
| Sep 30, 2024 | 0.36 |
API Access
Galectin Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();